分数各向异性分析有助于在临床环境中鉴别胶质母细胞瘤与脑转移瘤
回顾性纳入294例术前接受弥散张量成像的患者(胶质母细胞瘤165例、脑转移瘤129例),在强化肿瘤区、坏死区和FLAIR高信号非强化瘤周区测量分数各向异性(FA)。胶质母细胞瘤强化区FA中位数0.33显著高于脑转移瘤0.23(P<0.001),坏死区与瘤周区FA无显著差异;加入FA后两位神经放射科医师诊断AUC由0.84/0.85提升至0.89/0.92。
要点
- 强化肿瘤区FA中位数胶质母细胞瘤0.33 vs 脑转移瘤0.23,差异有统计学意义(P<0.001)。
- 坏死区FA(0.17 vs 0.18,P=0.37)与瘤周非强化区FA(0.21 vs 0.22,P=0.28)两组无显著差异。
- 结合FA值及FA彩色图后,两位阅片者诊断AUC分别由0.84、0.85提升至0.89、0.92。
核心结论
- 胶质母细胞瘤强化肿瘤部分的FA值显著高于脑转移瘤;在临床常规中引入基于ROI的FA测量和FA彩色图有助于鉴别胶质母细胞瘤与脑转移瘤。
研究设计与样本
- 回顾性研究,纳入294例术前接受弥散张量成像(DTI)的患者,其中胶质母细胞瘤165例、脑转移瘤129例;由两位神经放射科医师分别在不知晓和知晓FA值的情况下将病例分类为胶质母细胞瘤或脑转移瘤。
关键影像表现/征象
- 胶质母细胞瘤强化肿瘤区FA中位数0.33,脑转移瘤0.23,胶质母细胞瘤显著更高(P<0.001)。
- 瘤周FLAIR高信号非强化区FA胶质母细胞瘤0.21 vs 脑转移瘤0.22,无显著差异(P=0.28)。
- 坏死区FA胶质母细胞瘤0.17 vs 脑转移瘤0.18,无显著差异(P=0.37)。
诊断标准与关键数值
- FA测量采用感兴趣区(ROI)法,分别置于强化肿瘤、坏死区和FLAIR高信号非强化瘤周区。
- 未知晓FA值时两位阅片者诊断AUC分别为0.84(Reader1)和0.85(Reader2),知晓FA值后提升至0.89(Reader1)和0.92(Reader2)。
临床应用与阅片要点
- 在强化肿瘤区放置ROI测量FA值,并参考FA彩色图,可能有助于区分胶质母细胞瘤与脑转移瘤。
- 坏死区和瘤周非强化区的FA值在两组间无显著差异,判别价值有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Differentiating glioblastoma from brain metastases is important for therapy planning. Diffusion tensor imaging (DTI) was described as a promising tool, however with conflicting results.
AIM: of this study was to analyze the clinical utility of DTI for the differentiation of brain metastases and glioblastoma.
METHODS: 294 patients (165 glioblastoma, 129 brain metastases) with preoperative DTI were included in this retrospective study. Fractional anisotropy (FA) was measured via regions of interest (ROIs) in the contrast-enhancing tumor, the necrosis and the FLAIR-hyperintense non-enhancing peritumoral region (NEPTR). Two neuroradiologists classified patient cases as glioblastoma or brain metastases without and with knowledge of FA values.
RESULTS: Glioblastoma showed significantly higher FAcontrast (median glioblastoma=0.33, metastases=0.23; P<0.001) whereas no significant difference was observed for FANEPTR (0.21 vs. 0.22; P=0.28) and for FAnecrosis (0.17 vs. 0.18, P=0.37). FA improved diagnostic accuracy of the neuroradiologists significantly from an AUC of 0.84/0.85 (Reader1/Reader2) to 0.89/0.92.
CONCLUSIONS: Glioblastoma show significantly higher FA values in the contrast enhancing tumor part than brain metastases. Implementation of a ROI-based measurement of FA values and FA color maps in clinical routine helps to differentiate between glioblastoma and brain metastases.
引用
- Bette S, Huber T, Wiestler B, et al. Analysis of fractional anisotropy facilitates differentiation of glioblastoma and brain metastases in a clinical setting. Eur J Radiol. 2016. PMID: 27842664. doi:10.1016/j.ejrad.2016.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。